Dendrimers based cancer nanotheranostics: An overview
| Autor: | Yachana Mishra, Vijay Mishra, Vikrant Saluja, Namita Giri, Pallavi Nayak |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Therapy Outcome
Treatment response Dendrimers Computer science Pharmaceutical Science Cancer Nanotechnology 02 engineering and technology 021001 nanoscience & nanotechnology medicine.disease 030226 pharmacology & pharmacy Theranostic Nanomedicine Focal therapy 03 medical and health sciences 0302 clinical medicine Drug Delivery Systems Targeted drug delivery Dendrimer Neoplasms medicine Humans Tissue Distribution Nanocarriers Molecular imaging 0210 nano-technology |
| Zdroj: | International journal of pharmaceutics. 600 |
| ISSN: | 1873-3476 |
| Popis: | Cancer is a known deadliest disease that requires a judicious diagnostic, targeting, and treatment strategy for an early prognosis and selective therapy. The major pitfalls of the conventional approach are non-specificity in targeting, failure to precisely monitor therapy outcome, and cancer progression leading to malignancies. The unique physicochemical properties offered by nanotechnology derived nanocarriers have the potential to radically change the landscape of cancer diagnosis and therapeutic management. An integrative approach of utilizing both diagnostic and therapeutic functionality using a nanocarrier is termed as nanotheranostic. The nanotheranostics platform is designed in such a way that overcomes various biological barriers, efficiently targets the payload to the desired locus, and simultaneously supports planning, monitoring, and verification of treatment delivery to demonstrate an enhanced therapeutic efficacy. Thus, a nanotheranostic platform could potentially assist in drug targeting, image-guided focal therapy, drug release and distribution monitoring, predictionof treatment response, and patient stratification. A class of highly branched nanocarriers known as dendrimers is recognized as an advanced nanotheranostic platform that has the potential to revolutionize the oncology arena by its unique and exciting features. A dendrimer is a well-defined three-dimensional globular chemical architecture with a high level of monodispersity, amenability of precise size control, and surface functionalization. All the dendrimer properties exhibit a reproducible pharmacokinetic behavior that could ensure the desired biodistribution and efficacy. Dendrimers are thus being exploited as a nanotheranostic platform embodying a diverse class of therapeutic, imaging, and targeting moieties for cancer diagnosis and treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect